1. Impact on pulmonary, intestinal and metabolic compartments of chronic smoking exposure and unhealthy diet: a functional and multi-omic approach
- Author
-
E Pujos-Guillot, G Marot, Corinne Grangette, Isabelle Wolowczuk, Muriel Pichavant, E Picard, David Hot, Gwenola Kervoaze, and P. Gosset
- Subjects
Lung ,business.industry ,Physiology ,Inflammation ,medicine.disease ,Obesity ,Transcriptome ,medicine.anatomical_structure ,Metabolomics ,Immune system ,Insulin resistance ,medicine ,medicine.symptom ,business ,Weight gain - Abstract
Introduction: Smoking and unhealthy diet (SCUD) are risk factors involved in chronic obstructive pulmonary disease or obesity. Our aim is to better describe the impact of cigarette smoke (CS), associated with High Fat Diet (HFD), on pulmonary, intestinal and metabolic homeostasis and to identify physiopathologic mechanisms. Methods: C57Bl6 mice were subjected for 18 weeks to a HFD at 45% Kcal vs Low Fat Diet (LFD) at 10% Kcal. After 4 weeks, mice were exposed to CS or to filtered air. Lung function, anatomic, inflammatory and immune alterations as well as multi-omics studies were performed in these compartments. Results: SCUD revealed cumulative effect on the lung, with emphysema, tissues damage and immune cell recruitment. HFD induced weight gain, insulin resistance and glucose intolerance whereas CS limited these negative effects. However, SCUD induced visceral fat accumulation and inflammation vs HFD alone, associated with a specific metabolomics signature in the serum. Transcriptome analysis essentially revealed a HFD-related signature. Colon damage was moderate. However, metagenomics and metabolomics analyses in the caecum showed a specific signature due to SCUD, associated with some modifications in the colon transcriptoma. Conclusion: These results identify SCUD impacts on lung, metabolic and intestinal functions and reveal specific signatures related to combined exposure to unhealthy diet and CS. Bioinformatic analysis is ongoing to decipher the interactions between these compartments. These data will also allow to identify targets for preventive/therapeutic tools controling lung, intestinal and metabolic disorders due to SCUD.
- Published
- 2020
- Full Text
- View/download PDF